Canton Strategic Holdings (CNTN) Interest & Investment Income (2023 - 2026)
Canton Strategic Holdings posted quarterly Interest & Investment Income of $318178.0 for Q1 2026, up 2268.1% year-on-year from $13436.0 in Q1 2025, and up 1203.05% on a QoQ basis from $24418.0 in Q4 2025.
Canton Strategic Holdings (CNTN) has 4 years of Interest & Investment Income data on file, last reported at $318178.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 2268.1% year-over-year to $318178.0; the trailing twelve-month figure through Mar 2026 stood at $346152.0 (up 106.72% YoY), and the FY2025 full-year result was $41410.0, down 83.43% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $318178.0, up from $24418.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $318178.0 in Q1 2026 and bottomed at $1388.0 in Q3 2025.
- The 4-year median for Interest & Investment Income is $32248.0 (2023), against an average of $58625.2.
- The widest annual swing landed in 2025, when Interest & Investment Income slumped 98.09%; it then jumped 2268.1% in 2026.
- A 4-year view of Interest & Investment Income shows it stood at $57733.0 in 2023, then sank by 52.07% to $27672.0 in 2024, then declined by 11.76% to $24418.0 in 2025, then jumped by 1203.05% to $318178.0 in 2026.
- The last three Interest & Investment Income figures came in at $318178.0 (Q1 2026), $24418.0 (Q4 2025), and $1388.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - | 318,178.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 318,178.00 |
| Dec 31, 2025 | 24,418.00 |
| Sep 30, 2025 | 1,388.00 |
| Jun 30, 2025 | 2,168.00 |
| Mar 31, 2025 | 13,436.00 |
| Dec 31, 2024 | 27,672.00 |
| Sep 30, 2024 | 72,728.00 |
| Jun 30, 2024 | 53,614.00 |
| Mar 31, 2024 | 95,894.00 |
| Dec 31, 2023 | 57,733.00 |
| Sep 30, 2023 | 28,451.00 |
| Jun 30, 2023 | 34,199.00 |
| Mar 31, 2023 | 32,248.00 |